Fusion Antibodies PLC (FAB) — Strategic Asset Allocation Index
Fusion Antibodies PLC (FAB) has a Strategic Asset Allocation Index of 33.4% as of March 2023. Strategic assets (PP&E of GBX375.00K plus long-term investments of GBX-) total GBX375.00K, measured against net assets of GBX1.12 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Fusion Antibodies PLC Strategic Asset Allocation Index (2006–2023)
This chart shows how Fusion Antibodies PLC's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2023. As of March 2023, the index stands at 33.4%, representing strategic assets of GBX375.00K against net assets of GBX1.12 Million GBX. Explore Fusion Antibodies PLC (FAB) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Fusion Antibodies PLC (2006–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Fusion Antibodies PLC from 2006 to 2023, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Fusion Antibodies PLC market capitalisation.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 33.4% | GBX375.00K | GBX375.00K | GBX- | GBX1.12 Million | ▲ +16.2 pp |
| 2022 | 17.2% | GBX633.00K | GBX633.00K | GBX- | GBX3.68 Million | ▼ -6.5 pp |
| 2021 | 23.7% | GBX1.12 Million | GBX1.12 Million | GBX- | GBX4.75 Million | ▼ -6.9 pp |
| 2020 | 30.5% | GBX1.47 Million | GBX1.47 Million | GBX- | GBX4.81 Million | ▲ +0.9 pp |
| 2019 | 29.7% | GBX1.59 Million | GBX1.59 Million | GBX- | GBX5.35 Million | ▲ +21.3 pp |
| 2018 | 8.3% | GBX546.73K | GBX546.73K | GBX- | GBX6.58 Million | ▲ +2.0 pp |
| 2017 | 6.3% | GBX107.25K | GBX107.25K | GBX- | GBX1.71 Million | ▲ +2.9 pp |
| 2016 | 3.4% | GBX49.97K | GBX49.97K | GBX- | GBX1.46 Million | ▼ -270.4 pp |
| 2014 | 273.8% | GBX44.68K | GBX44.68K | GBX- | GBX16.32K | ▲ +164.1 pp |
| 2013 | 109.7% | GBX55.00K | GBX55.00K | GBX- | GBX50.13K | ▲ +66.1 pp |
| 2011 | 43.7% | GBX141.00K | GBX141.00K | GBX- | GBX323.00K | ▼ -5.8 pp |
| 2010 | 49.4% | GBX254.00K | GBX254.00K | GBX- | GBX514.00K | ▼ -116.5 pp |
| 2009 | 166.0% | GBX312.00K | GBX312.00K | GBX- | GBX188.00K | ▲ +115.1 pp |
| 2008 | 50.8% | GBX333.00K | GBX333.00K | GBX- | GBX655.00K | ▼ -16.6 pp |
| 2007 | 67.4% | GBX410.00K | GBX410.00K | GBX- | GBX608.00K | ▲ +13.5 pp |
| 2006 | 53.9% | GBX110.00K | GBX110.00K | GBX- | GBX204.00K | — |